All news articles for December 2017

(Image: Getty/DedMityay)

Guest article

2017 in review: Shaping the next-generation of clinical trials

By Leanne Madre, director of strategy, CTTI

This past year, the clinical trials landscape continued to shift and adapt to promising trends—including mobile technology, real-world data, and patient engagement—that can help us build a stronger clinical trials system.

GettyImages/Stas_V

Who has been hired, and how will they spend the holidays?

By Flora Southey

Recent pharma appointments include CEOs at Rubius Therapeutics and Neurotrope, and a COO/CFO at PMV Pharmaceuticals.

Scroll through the gallery to check out who has been hired where, and how these executives plan to spend the end of year...

(Image: iStock/macgverhh)

Top CRO and CMO M&A activity of 2017

By Top CRO and CMO M&A activity of 2017

Every week, another merger or acquisition (or so it seemed) as the industry continued to consolidate in 2017.

(Image: iStock/Gajus)

Regulatory roundup: Reviewing global changes in 2017

By Melissa Fassbender

The pharmaceutical industry made significant advancements towards global regulatory harmonization in 2017 – despite a highly-charged political environment on both sides of the Atlantic.

(Image: iStock/thomas-bethge)

Reports revisited: What we learned this year

By Melissa Fassbender

Outsourcing models examined, market shifts scrutinized, and trial tribulations analyzed – take a look back at some of the top reports published in 2017.

(Image: Getty/marchmeena29)

4 trends driving industry priorities in 2018

By Melissa Fassbender

Commercial transformation could reach new heights in 2018, says inVentiv – as new expectations (and possibilities) reshape traditional models.

Gettyimages/grThirteen

News in brief

Colorcon and Applied DNA Sciences sign tech MOU

By Staff reporter

Colorcon Inc. and Applied DNA Sciences Inc. have teamed up to commercialize an on-dose traceability platform they say will help combat counterfeits.

(Image: Getty/SARINYAPINNGAM)

7 Predictions for 2018

By Melissa Fassbender

In 2018, the industry can expect risk-based everything, cloud-first strategies, and a focus on modernization as companies look to stand out amongst the competition, say Veeva Systems execs.

(Image: Getty/tortoon)

Guest article

Looking over the horizon: 2018 and beyond

By Doug Peddicord, PhD, executive director of the Association of Clinical Research Organizations (ACRO)

As the great Yogi Berra once said, “It’s tough to make predictions, especially about the future.” But it is safe to say that after a year of considerable consolidation and change, the CRO industry anticipates continuing and potentially rapid evolution...

Gettyimages/wildpixe

update - CEO: ideal model is two to four API plants and six to eight drug facilities

Teva confirms plan to reduce workforce by 14,000 to save $3bn

By Gareth Macdonald

Teva Pharmaceutical Industries will reduce its workforce by 14,000, rejig its generics portfolio and speed up optimization of its plant network as part of a $3bn (€2.5bn) cost saving plan.

(Image: Getty/RomoloTavani)

Guest article

3 global trends driving transformations in healthcare product development

By Sudip S. Parikh, PhD, senior vice president & managing director, DIA Americas

The healthcare product development ecosystem is undergoing massive changes. Significant transformations are underway in how drugs and medical devices are researched, developed, manufactured, and approved.